Silvercrest Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.6M Sell
75,487
-9,443
-11% -$3.37M 0.19% 149
2025
Q4
$27.8M Sell
84,930
-30
-0% -$9.52K 0.19% 145
2025
Q3
$24M Sell
84,960
-4,132
-5% -$1.2M 0.16% 174
2025
Q2
$24.9M Sell
89,092
-17,867
-17% -$5.06M 0.17% 173
2025
Q1
$33.3M Sell
106,959
-11,744
-10% -$3.47M 0.24% 124
2024
Q4
$30.9M Sell
118,703
-104,268
-47% -$30.9M 0.21% 137
2024
Q3
$71.8M Sell
222,971
-4,635
-2% -$1.52M 0.49% 65
2024
Q2
$71.1M Sell
227,606
-3,917
-2% -$1.15M 0.49% 59
2024
Q1
$65.8M Buy
231,523
+319
+0.1% +$93.3K 0.45% 70
2023
Q4
$66.6M Sell
231,204
-11,414
-5% -$3.11M 0.47% 72
2023
Q3
$65.2M Sell
242,618
-12,788
-5% -$3.19M 0.5% 65
2023
Q2
$56.7M Sell
255,406
-42,896
-14% -$9.95M 0.4% 92
2023
Q1
$72.1M Sell
298,302
-6,477
-2% -$1.59M 0.55% 54
2022
Q4
$80M Sell
304,779
-2,086
-0.7% -$559K 0.62% 48
2022
Q3
$69.2M Sell
306,865
-4,424
-1% -$1.07M 0.57% 59
2022
Q2
$75.7M Buy
311,289
+1,545
+0.5% +$379K 0.58% 56
2022
Q1
$74.9M Buy
309,744
+3,412
+1% +$784K 0.49% 68
2021
Q4
$68.9M Sell
306,332
-54,188
-15% -$11.4M 0.44% 81
2021
Q3
$76.7M Sell
360,520
-3,948
-1% -$909K 0.52% 61
2021
Q2
$88.8M Buy
364,468
+3,546
+1% +$872K 0.58% 45
2021
Q1
$89.8M Buy
360,922
+54,997
+18% +$13.1M 0.61% 46
2020
Q4
$70.3M Sell
305,925
-54,047
-15% -$12.5M 0.51% 70
2020
Q3
$91.5M Sell
359,972
-4,506
-1% -$1.12M 0.79% 28
2020
Q2
$86M Sell
364,478
-1,261
-0.3% -$288K 0.76% 25
2020
Q1
$74.1M Sell
365,739
-652
-0.2% -$142K 0.8% 29
2019
Q4
$88.3M Buy
366,391
+3,035
+0.8% +$669K 0.69% 42
2019
Q3
$70.3M Buy
363,356
+894
+0.2% +$172K 0.58% 59
2019
Q2
$66.8M Buy
362,462
+43,079
+13% +$7.71M 0.63% 58
2019
Q1
$60.7M Buy
319,383
+7,989
+3% +$1.53M 0.6% 64
2018
Q4
$60.6M Sell
311,394
-853
-0.3% -$166K 0.67% 56
2018
Q3
$64.7M Buy
312,247
+35,037
+13% +$6.9M 0.59% 65
2018
Q2
$51.2M Buy
277,210
+3,154
+1% +$558K 0.48% 85
2018
Q1
$46.7M Buy
274,056
+8,959
+3% +$1.64M 0.46% 92
2017
Q4
$46.1M Buy
265,097
+21,250
+9% +$3.76M 0.43% 97
2017
Q3
$45.5M Buy
243,847
+5,994
+3% +$1.06M 0.45% 85
2017
Q2
$41M Buy
237,853
+265
+0.1% +$43.1K 0.44% 89
2017
Q1
$39M Buy
237,588
+28,151
+13% +$4.68M 0.42% 96
2016
Q4
$30.6M Sell
209,437
-29,553
-12% -$4.45M 0.34% 104
2016
Q3
$39.9M Sell
238,990
-2,548
-1% -$431K 0.48% 88
2016
Q2
$36.8M Buy
241,538
+951
+0.4% +$148K 0.47% 89
2016
Q1
$36.1M Sell
240,587
-27,405
-10% -$4.07M 0.5% 82
2015
Q4
$43.5M Buy
267,992
+7,436
+3% +$1.17M 0.6% 64
2015
Q3
$36M Buy
260,556
+5,979
+2% +$942K 0.55% 79
2015
Q2
$39.1M Buy
254,577
+82,170
+48% +$13.2M 0.52% 74
2015
Q1
$27.6M Buy
172,407
+11,478
+7% +$1.81M 0.39% 95
2014
Q4
$25.6M Buy
160,929
+64,679
+67% +$10.1M 0.37% 95
2014
Q3
$13.5M Hold
96,250
0.21% 129
2014
Q2
$11.4M Buy
96,250
+1,580
+2% +$183K 0.17% 140
2014
Q1
$11.7M Sell
94,670
-1,160
-1% -$141K 0.19% 133
2013
Q4
$10.9M Sell
95,830
-325
-0.3% -$37K 0.18% 133
2013
Q3
$10.8M Sell
96,155
-104
-0.1% -$11.3K 0.21% 124
2013
Q2
$9.5M Buy
+96,259
New +$9.99M 0.2% 125

Other funds holding AMGN

Silvercrest Asset Management's AMGN Position: Q1 2026 in Review

Silvercrest Asset Management reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $3.37M and leaving 75,487 shares worth $26.6M. The position accounts for 0.19% of the portfolio, ranked #149.

Silvercrest Asset Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $91.5M in Q3 2020. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Silvercrest Asset Management held 75,487 shares of Amgen worth $26.6M as of Q1 2026.
  • Silvercrest Asset Management sold 9,443 Amgen shares in Q1 2026, an estimated $3.37M.
  • Amgen made up 0.19% of Silvercrest Asset Management's portfolio in Q1 2026, its #149 holding.
  • Silvercrest Asset Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Silvercrest Asset Management's Amgen position peaked at $91.5M in Q3 2020.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.